Powered Echelon Device in VATS Surgery
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Device: Endocutter
- Registration Number
- NCT01843192
- Lead Sponsor
- Ethicon Endo-Surgery
- Brief Summary
This study aims to collect real world outcomes of Video-Assisted Thoracoscopic Surgery (VATS) for lung cancer (lobectomy, wedge resection) using ECHELON FLEX™ Powered ENDOPATH® Staplers 45 mm and/or 60 mm (study devices).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 71
- Suspected or confirmed NSCLC (up to and including Stage II)
- Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
- Performance status 0-1 (Eastern Cooperative Oncology Group classification)
- ASA score < 3
- No prior history of VATS or open lung surgery
- Willing to give consent and comply with study-related evaluation and treatment schedule
- Active bacterial infection or fungal infection;
- Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
- Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
- Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed)
- Pregnancy
- Physical or psychological condition which would impair study participation;
- The patient is judged unsuitable for study participation by the Investigator for any other reason; or
- Unable or unwilling to attend follow-up visits and examinations
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description VATS for suspected or confirmed NSCLC Endocutter Single arm study
- Primary Outcome Measures
Name Time Method Occurrence of Prolonged Air Leaks Post-operative period through hospital discharge and follow-up at Day 30 Prolonged air leaks defined as longer than 5 days in continuous duration. Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).
Occurrence of Postoperative Air Leaks Post-operative period through hospital discharge and follow-up at Day 30 Air leak was to be quantitatively assessed starting on the evening after surgery and then twice daily (during morning and evening rounds) as described by Certfolio et al. 2001. Patients were instructed to perform standardized repeated forced expiratory maneuvers (coughing and blowing). Leaks were scored using the air-leak meter that comes as part of a pleura vac system from 1 to 7, with 7 being the highest (most chambers).
- Secondary Outcome Measures
Name Time Method Operative Time Day of surgery Defined as the duration in hours from the first skin incision to the closure of the last incision
Occurrence of Intra-operative Leak Test During surgery This outcome was scored as Yes or No based on whether a leak was detected during an intra-operative leak test when it was performed. Not all subjects had an intra-operative leak test performed, as it was not standard of care at all participating institutions, and so results are only presented for those subjects in whom an intra-operative test was performed.
Time to Chest Tube Removal Post-operative period through hospital discharge and follow-up at Day 30 Defined as the number of days from date of surgery to removal of the last chest tube inserted during the surgical procedure.
Length of Stay (LOS) Post-operative period through hospital discharge and follow-up at Day 30 Determined as the length of time in days from hospital admission to initial hospital discharge
Volume of Estimated Intra-operative Blood Loss Blood loss intra-op and up to 5 days post-op Number of Subjects With 1 Chest Tube Placed During surgery All subjects had either 1 or 2 chest tubes placed during surgery. Results presented are for the percentage of subjects with 1 chest tube placed.
Trial Locations
- Locations (4)
Dignity Health, St. Joseph's Hospital & Medical Center
🇺🇸Phoenix, Arizona, United States
Washington University School of Medicine
🇺🇸St. Louis, Missouri, United States
Vanderbilt University
🇺🇸Nashville, Tennessee, United States
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States